Michael May, MD

Michael May, MD

Memorial Sloan Kettering Cancer Center

Latest Content

Two medical professionals, a woman and a man, in white coats with a city skyline background, discussing RAS-targeted therapy in pancreatic adenocarcinoma.

Pancreatic Cancer

06/19/2026

Daraxonrasib and the Future of RAS Inhibitors in Pancreatic Cancer

Antonella Cammarota, PhDMichael May, MD